{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T05:51:57Z","timestamp":1778219517844,"version":"3.51.4"},"reference-count":40,"publisher":"Oxford University Press (OUP)","issue":"Supplement_2","license":[{"start":{"date-parts":[[2019,3,8]],"date-time":"2019-03-08T00:00:00Z","timestamp":1552003200000},"content-version":"vor","delay-in-days":1,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","award":["OPP1116967"],"award-info":[{"award-number":["OPP1116967"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","award":["OPP1151153"],"award-info":[{"award-number":["OPP1151153"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["106158\/Z\/14\/Z"],"award-info":[{"award-number":["106158\/Z\/14\/Z"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["1K01AI119603"],"award-info":[{"award-number":["1K01AI119603"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,3,7]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Empiric prescribing of antimicrobials in typhoid-endemic settings has increased selective pressure on the development of antimicrobial-resistant Salmonella enterica serovar Typhi. The introduction of typhoid conjugate vaccines (TCVs) in these settings may relieve this selective pressure, thereby reducing resistant infections and improving health outcomes.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>A deterministic transmission dynamic model was developed to simulate the impact of TCVs on the number and proportion of antimicrobial-resistant typhoid infections and chronic carriers. One-way sensitivity analyses were performed to ascertain particularly impactful model parameters influencing the proportion of antimicrobial-resistant infections and the proportion of cases averted over 10 years.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>The model simulations suggested that increasing vaccination coverage would decrease the total number of antimicrobial-resistant typhoid infections but not affect the proportion of cases that were antimicrobial resistant. In the base-case scenario with 80% vaccination coverage, 35% of all typhoid infections were antimicrobial resistant, and 44% of the total cases were averted over 10 years by vaccination. Vaccination also decreased both the total number and proportion of chronic carriers of antimicrobial-resistant infections. The prevalence of chronic carriers, recovery rates from infection, and relative fitness of resistant strains were identified as crucially important parameters.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Model predictions for the proportion of antimicrobial resistant infections and number of cases averted depended strongly on the relative fitness of the resistant strain(s), prevalence of chronic carriers, and rates of recovery without treatment. Further elucidation of these parameter values in real-world typhoid-endemic settings will improve model predictions and assist in targeting future vaccination campaigns and treatment strategies.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/cid\/ciy1108","type":"journal-article","created":{"date-parts":[[2019,1,8]],"date-time":"2019-01-08T22:33:10Z","timestamp":1546986790000},"page":"S96-S104","source":"Crossref","is-referenced-by-count":31,"title":["Predicting the Impact of Typhoid Conjugate Vaccines on Antimicrobial Resistance"],"prefix":"10.1093","volume":"68","author":[{"given":"Samantha","family":"Kaufhold","sequence":"first","affiliation":[{"name":"Department of Epidemiology of Microbial Diseases, Yale School of Public Health, Yale University, New Haven, Connecticut"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reza","family":"Yaesoubi","sequence":"additional","affiliation":[{"name":"Department of Health Policy and Management, Yale School of Public Health, Yale University, New Haven, Connecticut"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Virginia E","family":"Pitzer","sequence":"additional","affiliation":[{"name":"Department of Epidemiology of Microbial Diseases, Yale School of Public Health, Yale University, New Haven, Connecticut"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2019,3,7]]},"reference":[{"key":"2019121022401302900_CIT0001","doi-asserted-by":"crossref","first-page":"e0005376","DOI":"10.1371\/journal.pntd.0005376","article-title":"The burden of typhoid fever in low- and middle-income countries: a meta-regression approach","volume":"11","author":"Antill\u00f3n","year":"2017","journal-title":"PLoS Negl Trop Dis"},{"key":"2019121022401302900_CIT0002","doi-asserted-by":"crossref","first-page":"e570","DOI":"10.1016\/S2214-109X(14)70301-8","article-title":"Burden of typhoid fever in low-income and middle-income countries: a systematic, literature-based update with risk-factor adjustment","volume":"2","author":"Mogasale","year":"2014","journal-title":"Lancet Glob Health"},{"key":"2019121022401302900_CIT0003","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1146\/annurev-micro-091313-103739","article-title":"Salmonella enterica serovar Typhi and the pathogenesis of typhoid fever","volume":"68","author":"Dougan","year":"2014","journal-title":"Annu Rev Microbiol"},{"key":"2019121022401302900_CIT0004","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1136\/adc.75.3.214","article-title":"Impact of age and drug resistance on mortality in typhoid fever","volume":"75","author":"Bhutta","year":"1996","journal-title":"Arch Dis Child"},{"key":"2019121022401302900_CIT0005","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1093\/cid\/ciy190","article-title":"Case fatality rate of enteric fever in endemic countries: a systematic review and meta-analysis","volume":"67","author":"Pieters","year":"2018","journal-title":"Clin Infect Dis"},{"key":"2019121022401302900_CIT0006","first-page":"153","article-title":"Typhoid vaccines: WHO position paper \u2014 March 2018","volume":"93","year":"2018","journal-title":"Weekly Epidemiological Record"},{"key":"2019121022401302900_CIT0007","doi-asserted-by":"crossref","first-page":"S214","DOI":"10.1093\/infdis\/jix221","article-title":"High rates of enteric fever diagnosis and lower burden of culture-confirmed disease in peri-urban and rural Nepal","volume":"218","author":"Andrews","year":"2018","journal-title":"J Infect Dis"},{"key":"2019121022401302900_CIT0008","doi-asserted-by":"crossref","first-page":"e0004616","DOI":"10.1371\/journal.pntd.0004616","article-title":"The burden of typhoid and paratyphoid in India: systematic review and meta-analysis","volume":"10","author":"John","year":"2016","journal-title":"PLoS Negl Trop Dis"},{"key":"2019121022401302900_CIT0009","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1038\/ng.3281","article-title":"Phylogeographical analysis of the dominant multidrug-resistant H58 clade of Salmonella Typhi identifies inter- and intracontinental transmission events","volume":"47","author":"Wong","year":"2015","journal-title":"Nat Genet"},{"issue":"1","key":"2019121022401302900_CIT0010","doi-asserted-by":"crossref","first-page":"e00105","DOI":"10.1128\/mBio.00105-18","article-title":"Emergence of an extensively drug-resistant Salmonella enterica serovar Typhi clone harboring a promiscuous plasmid encoding resistance to fluoroquinolones and third-generation cephalosporins","volume":"9","author":"Klemm","year":"2018","journal-title":"MBio"},{"key":"2019121022401302900_CIT0011","doi-asserted-by":"crossref","first-page":"E26","DOI":"10.1016\/S1473-3099(18)30350-5","article-title":"Typhoid conjugate vaccines: a new tool in the fight against antimicrobial resistance","volume":"19","author":"Andrews","year":"2018","journal-title":"Lancet Infect Dis"},{"key":"2019121022401302900_CIT0012","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/S0140-6736(15)00474-2","article-title":"Access to effective antimicrobials: a worldwide challenge","volume":"387","author":"Laxminarayan","year":"2016","journal-title":"Lancet"},{"key":"2019121022401302900_CIT0013","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1093\/infdis\/jir755","article-title":"Prevention of antibiotic-nonsusceptible Streptococcus pneumoniae with conjugate vaccines","volume":"205","author":"Hampton","year":"2012","journal-title":"J Infect Dis"},{"key":"2019121022401302900_CIT0014","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1093\/cid\/civ295","article-title":"Safety and immunogenicity of a Vi polysaccharide-tetanus toxoid conjugate vaccine (Typbar-TCV) in healthy infants, children, and adults in typhoid endemic areas: a multicenter, 2-cohort, open-label, double-blind, randomized controlled phase 3 study","volume":"61","author":"Mohan","year":"2015","journal-title":"Clin Infect Dis"},{"key":"2019121022401302900_CIT0015","doi-asserted-by":"crossref","first-page":"2472","DOI":"10.1016\/S0140-6736(17)32149-9","article-title":"Efficacy and immunogenicity of a Vi-tetanus toxoid conjugate vaccine in the prevention of typhoid fever using a controlled human infection model of Salmonella Typhi: a randomised controlled, phase 2b trial","volume":"390","author":"Jin","year":"2017","journal-title":"Lancet"},{"key":"2019121022401302900_CIT0016","doi-asserted-by":"crossref","first-page":"3506","DOI":"10.1016\/j.vaccine.2017.05.001","article-title":"Cost-effectiveness analysis of typhoid conjugate vaccines in five endemic low- and middle-income settings","volume":"35","author":"Antill\u00f3n","year":"2017","journal-title":"Vaccine"},{"key":"2019121022401302900_CIT0017","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1093\/infdis\/jix598","article-title":"Comparison of strategies and incidence thresholds for Vi conjugate vaccines against typhoid fever: a cost-effectiveness modeling study","volume":"218","author":"Lo","year":"2018","journal-title":"J Infect Dis"},{"key":"2019121022401302900_CIT0018","doi-asserted-by":"crossref","first-page":"e2642","DOI":"10.1371\/journal.pntd.0002642","article-title":"Predicting the impact of vaccination on the transmission dynamics of typhoid in South Asia: a mathematical modeling study","volume":"8","author":"Pitzer","year":"2014","journal-title":"PLoS Negl Trop Dis"},{"key":"2019121022401302900_CIT0019","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1056\/NEJM197009242831306","article-title":"Typhoid fever: pathogenesis and immunologic control","volume":"283","author":"Hornick","year":"1970","journal-title":"N Engl J Med"},{"key":"2019121022401302900_CIT0020","doi-asserted-by":"crossref","first-page":"S251","DOI":"10.1093\/cid\/civ710","article-title":"Mathematical modeling to assess the drivers of the recent emergence of typhoid fever in Blantyre, Malawi","volume":"61","author":"Pitzer","year":"2015","journal-title":"Clin Infect Dis"},{"key":"2019121022401302900_CIT0021","first-page":"346","article-title":"The global burden of typhoid fever","volume":"82","author":"Crump","year":"2004","journal-title":"Bull World Health Organ"},{"key":"2019121022401302900_CIT0022","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1056\/NEJM197010012831406","article-title":"Typhoid fever: pathogenesis and immunologic control. 2","volume":"283","author":"Hornick","year":"1970","journal-title":"N Engl J Med"},{"key":"2019121022401302900_CIT0023","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1093\/cid\/cix1145","article-title":"Seroefficacy of Vi polysaccharide-tetanus toxoid typhoid conjugate vaccine (Typbar TCV)","volume":"67","author":"Voysey","year":"2018","journal-title":"Clin Infect Dis"},{"key":"2019121022401302900_CIT0024","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1056\/NEJM200104263441701","article-title":"The efficacy of a Salmonella Typhi Vi conjugate vaccine in two-to-five-year-old children","volume":"344","author":"Lin","year":"2001","journal-title":"N Engl J Med"},{"key":"2019121022401302900_CIT0025","article-title":"The impact of vaccination and prior exposure on stool shedding of Salmonella Typhi and Salmonella paratyphi in 6 controlled human infection studies","author":"Gibani","year":"2018","journal-title":"Clin Infect Dis"},{"key":"2019121022401302900_CIT0026","doi-asserted-by":"crossref","first-page":"S56","DOI":"10.1093\/cid\/civ891","article-title":"Utilization of healthcare in the typhoid fever surveillance in Africa Program","volume":"62","author":"Panzner","year":"2016","journal-title":"Clin Infect Dis"},{"key":"2019121022401302900_CIT0027","doi-asserted-by":"crossref","first-page":"e01229","DOI":"10.7554\/eLife.01229","article-title":"Fitness benefits in fluoroquinolone-resistant Salmonella Typhi in the absence of antimicrobial pressure","volume":"2","author":"Baker","year":"2013","journal-title":"Elife"},{"key":"2019121022401302900_CIT0028","doi-asserted-by":"crossref","first-page":"221","DOI":"10.2105\/AJPH.33.3.221","article-title":"Age and sex as factors in the development of the typhoid carrier state, and a method for estimating carrier prevalence","volume":"33","author":"Ames","year":"1943","journal-title":"Am J Public Health Nations Health"},{"key":"2019121022401302900_CIT0029","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/j.tim.2014.06.007","article-title":"Salmonella chronic carriage: epidemiology, diagnosis, and gallbladder persistence","volume":"22","author":"Gunn","year":"2014","journal-title":"Trends Microbiol"},{"key":"2019121022401302900_CIT0030","doi-asserted-by":"crossref","first-page":"260","DOI":"10.2471\/BLT.06.039818","article-title":"A study of typhoid fever in five Asian countries: disease burden and implications for controls","volume":"86","author":"Ochiai","year":"2008","journal-title":"Bull World Health Organ"},{"key":"2019121022401302900_CIT0031","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1136\/bmj.312.7024.160","article-title":"Changing patterns of invasive Haemophilus influenzae disease in England and Wales after introduction of the Hib vaccination programme","volume":"312","author":"Hargreaves","year":"1996","journal-title":"BMJ"},{"key":"2019121022401302900_CIT0032","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1128\/AAC.49.6.2561-2564.2005","article-title":"Decreasing prevalence of beta-lactamase production among respiratory tract isolates of Haemophilus influenzae in the United States","volume":"49","author":"Heilmann","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"2019121022401302900_CIT0033","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1093\/cid\/ciw067","article-title":"Prevention of antibiotic-nonsusceptible invasive pneumococcal disease with the 13-valent pneumococcal conjugate vaccine","volume":"62","author":"Tomczyk","year":"2016","journal-title":"Clin Infect Dis"},{"key":"2019121022401302900_CIT0034","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/S2213-2600(16)00052-7","article-title":"Effectiveness of 13-valent pneumococcal conjugate vaccine for prevention of invasive pneumococcal disease in children in the USA: a matched case-control study","volume":"4","author":"Moore","year":"2016","journal-title":"Lancet Respir Med"},{"key":"2019121022401302900_CIT0035","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1038\/nm.4465","article-title":"The role of vaccines in preventing bacterial antimicrobial resistance","volume":"24","author":"Jansen","year":"2018","journal-title":"Nat Med"},{"key":"2019121022401302900_CIT0036","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1093\/infdis\/157.6.1235","article-title":"Efficacy of ciprofloxacin in the treatment of chronic typhoid carriers","volume":"157","author":"Ferreccio","year":"1988","journal-title":"J Infect Dis"},{"key":"2019121022401302900_CIT0037","doi-asserted-by":"crossref","first-page":"e47342","DOI":"10.1371\/journal.pone.0047342","article-title":"The microbiological and clinical characteristics of invasive salmonella in gallbladders from cholecystectomy patients in Kathmandu, Nepal","volume":"7","author":"Dongol","year":"2012","journal-title":"Plos One"},{"key":"2019121022401302900_CIT0038","doi-asserted-by":"crossref","first-page":"e0003748","DOI":"10.1371\/journal.pntd.0003748","article-title":"Rapid emergence of multidrug resistant, H58-lineage Salmonella Typhi in Blantyre, Malawi","volume":"9","author":"Feasey","year":"2015","journal-title":"PLoS Negl Trop Dis"},{"key":"2019121022401302900_CIT0039","doi-asserted-by":"crossref","first-page":"e1245","DOI":"10.1371\/journal.pntd.0001245","article-title":"Emergence of a globally dominant IncHI1 plasmid type associated with multiple drug resistant typhoid","volume":"5","author":"Holt","year":"2011","journal-title":"PLoS Negl Trop Dis"},{"key":"2019121022401302900_CIT0040","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/S0140-6736(87)90319-9","article-title":"Persistent gallbladder carriage of Salmonella Typhi","volume":"1","author":"Sinnott","year":"1987","journal-title":"Lancet"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/cid\/article-pdf\/68\/Supplement_2\/S96\/28023933\/ciy1108.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/cid\/article-pdf\/68\/Supplement_2\/S96\/28023933\/ciy1108.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,12,10]],"date-time":"2019-12-10T22:46:56Z","timestamp":1576018016000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article\/68\/Supplement_2\/S96\/5371224"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,7]]},"references-count":40,"journal-issue":{"issue":"Supplement_2","published-online":{"date-parts":[[2019,3,7]]},"published-print":{"date-parts":[[2019,3,7]]}},"URL":"https:\/\/doi.org\/10.1093\/cid\/ciy1108","relation":{},"ISSN":["1058-4838","1537-6591"],"issn-type":[{"value":"1058-4838","type":"print"},{"value":"1537-6591","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,3,15]]},"published":{"date-parts":[[2019,3,7]]}}}